$SRAX “Tiny Gems” SRAX, Inc. Newsletter 6:03:59 AM August 5, 2020

on August 5, 2020 Newsletters and Tags: , , , , , , , , , , with 0 comments

SRAX Promotional Newsletter

The following is a newsletter released by "Tiny Gems" promoting SRAX, Inc.

Caution

The following newsletter has not been verified for accuracy or completeness.

Welcome to your 1 source of undiscovered, undervalued companies

This Month's Tiny Gems - August 2020

Featured Company

Net Element NASDAQ NETE

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen's stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. NASDAQ NETE is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

DarioHealth Corp. NASDAQ DRIO

New York and Israel-based DarioHealth Corp. NASDAQ DRIO leads global digital therapeutics DTx with its popular, smartphone-centered personalized chronic illness management software-as-a-service SaaS. The company's strategic advantages include AI-powered digital solutions that drive durable behavior change in chronic disease patients, and Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Energy Fuels Inc. NYSE American UUUU TSX EFR

Energy Fuels Inc. NYSE American UUUU TSX EFR, based in Lakewood, Colorado, is the country's largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels' uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company's assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Net Element NASDAQ NETE

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen's stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. NASDAQ NETE is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Predictive Oncology NASDAQ POAI

Predictive Oncology NASDAQ POAI is a knowledge-driven precision medicine company focused on applying data and artificial intelligence AI to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology's portfolio of assets includes the following A database of clinically validated historical and outcome data from patient tumors An in-house Clinical Laboratory Improvement Amendments CLIA-certified lab A smart patient-derived tumor profiling platform An in-house bioinformatics artificial intelligence AI platform A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options An FDA-approved fluid collection and disposal system

Pressure BioSciences Inc. PBIO

Pressure BioSciences, Inc. PBIO develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company's product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology PCT. PCT uses alternating cycles of hydrostatic pressure between ambient 14.5 psi and ultra-high levels up to 100,000 psi to safely and reproducibly control critical biological processes, such as the lysis breakage of cells, the digestion of proteins, and the inactivation of pathogens.

SRAX Inc. NASDAQ SRAX

SRAX Inc. NASDAQ SRAX is a digital marketing and consumer data management technology company. SRAX's technology unlocks data to reveal brands' core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

The Alkaline Water Company Inc. NASDAQ WTER CSE WTER

Founded in 2012, The Alkaline Water Company Inc. NASDAQ WTER CSE WTER is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company's trademarked label 'Clean Beverage'. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBD brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Trxade Group Inc. NASDAQ MEDS

Trxade Group Inc. NASDAQ MEDS is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform www.trxade.com for transactions between independent pharmacists and drug distributors B2B a network of pharmacies with E-Hub software a mail order pharmacy and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

8033 Sunset Blvd
Suite 1037
Los Angeles CA 90046
USA